These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Nabhan C; Ollberding NJ; Villines D; Chiu BC; Caces DB; Valdez TV; Ghielmini M; Hsu Schmitz SF; Smith SM Leuk Lymphoma; 2014 Jun; 55(6):1288-94. PubMed ID: 23998254 [TBL] [Abstract][Full Text] [Related]
11. Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy. Palacios T; Bartelt L; Scheld W; Lopes MB; Kelting SM; Holland S; Lipkin WI; Quan PL; Borish L; Lawrence M Ann Allergy Asthma Immunol; 2015 Aug; 115(2):148-50. PubMed ID: 26048250 [No Abstract] [Full Text] [Related]
12. Maintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma. Rashidi A; Oak E; Bartlett NL Blood; 2015 May; 125(21):3354-5. PubMed ID: 25999445 [No Abstract] [Full Text] [Related]
14. [Rituximab-induced interstitial lung disease]. Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535 [TBL] [Abstract][Full Text] [Related]
15. Enteroviral encephalitis in a patient with a marginal zone lymphomatreated with rituximab. Schilthuizen C; Berenschot HW; Levin MD Neth J Med; 2010 May; 68(5):221-3. PubMed ID: 20508271 [TBL] [Abstract][Full Text] [Related]
16. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Ardeshna KM; Qian W; Smith P; Braganca N; Lowry L; Patrick P; Warden J; Stevens L; Pocock CF; Miall F; Cunningham D; Davies J; Jack A; Stephens R; Walewski J; Ferhanoglu B; Bradstock K; Linch DC Lancet Oncol; 2014 Apr; 15(4):424-35. PubMed ID: 24602760 [TBL] [Abstract][Full Text] [Related]
17. Optimization of postremission therapy in follicular lymphoma: efficacy of rituximab maintenance. Roy R; Gordon LI J Natl Compr Canc Netw; 2011 May; 9(5):563-71. PubMed ID: 21550969 [TBL] [Abstract][Full Text] [Related]
18. Balancing immunosuppression and infection: recurrent enterovirus encephalitis in SLE. Cheema S; Bunting E; Good C; Hajela V; Ridha BH; Saha RA Pract Neurol; 2019 Dec; 19(6):508-510. PubMed ID: 31171649 [TBL] [Abstract][Full Text] [Related]
19. Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials. Vidal L; Gafter-Gvili A; Salles G; Dreyling MH; Ghielmini M; Hsu Schmitz SF; Pettengell R; Witzens-Harig M; Shpilberg O J Natl Cancer Inst; 2011 Dec; 103(23):1799-806. PubMed ID: 22021664 [TBL] [Abstract][Full Text] [Related]
20. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. Karrasch M; Fischer E; Scholten M; Sauerbrei A; Henke A; Renz DM; Mentzel HJ; Böer K; Böttcher S; Diedrich S; Krumbholz A; Zell R J Clin Virol; 2016 Nov; 84():90-95. PubMed ID: 27771495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]